Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
September 30, 2019 3:14 PM 2 min read

Micron Analyst Says Lower DRAM Prices Over First Half Of 2020 Will Delay Margin Recovery

by Wayne Duggan Benzinga Staff Writer
Follow
MU Logo
MUMicron Technology Inc
$410.31-0.50%
Overview

Micron Technology, Inc. (NASDAQ:MU) shares are down 11.6% since the company’s earnings and guidance disappointed the market last week.

Investors were hoping Micron’s memory market would recover in the second half of 2019, but one Wall Street analyst said Friday that the DRAM market may not be back on solid ground until the second half of 2020.

The Analyst

Raymond James analyst Chris Caso reiterated a Market Perform rating on Micron.

The Thesis

DRAM volume was up 30% quarter-over-quarter, but pricing was down 20%, Caso said in a Friday note. (See his track record here.)

NAND volume growth was in the low double-digit percentage range, while pricing dropped in the high single-digits, the analyst said. 

“Looking forward, as we noted in our Asia update earlier this week, our checks suggest the combination of excess inventory and seasonality is likely to send DRAM prices back lower through 1H20, which would serve to delay the recovery of margins. Importantly, with cost coming down more slowly than in the past, DRAM margin recovery will likely be dependent on sustained DRAM price improvement, which we don’t think will occur until 2H20.”  

Micron guided for fiscal 2020 capex of between $7 billion and $8 billion, down 30% from a year ago.

Following the earnings report, Raymond James lowered its fiscal 2020 non-GAAP EPS estimate from $2.92 to $2.24, which is based on a mid-teens percentage decline in revenue and continued margin pressures.

In addition, the firm initiated a calendar 2021 EPS estimate of $4.80.

Benzinga’s Take

The good news for Micron investors is that the memory market will eventually balance out and the next cyclical pricing upswing will be a tailwind for the stock. The bad news is that the upswing — and share price recovery — may take longer to materialize than investors had hoped.

Do you agree with this take? Email [email protected] with your thoughts.

Related Links:

How Large Option Traders Are Playing The Micron Earnings Dip

PreMarket Prep Recap: Micron Earnings, Wells Fargo's New CEO

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorReiterationAnalyst RatingsChris CasoRaymond James
MU Logo
MUMicron Technology Inc
$410.31-0.50%
Overview
Comments
Loading...